Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other financing activities: 2020-2023

Historic Other financing activities for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2023 value amounting to $7.5 million.

  • Cullinan Therapeutics' Other financing activities fell 71.95% to $7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $30.4 million, marking a year-over-year decrease of 35.58%. This contributed to the annual value of $37.8 million for FY2024, which is 24.27% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Other financing activities stood at $7.5 million for Q4 2023, which was down 2.86% from $7.7 million recorded in Q3 2023.
  • In the past 5 years, Cullinan Therapeutics' Other financing activities ranged from a high of $26.8 million in Q4 2022 and a low of $3.5 million during Q1 2021.
  • Moreover, its 3-year median value for Other financing activities was $7.4 million (2023), whereas its average is $9.3 million.
  • In the last 5 years, Cullinan Therapeutics' Other financing activities surged by 106.67% in 2022 and then plummeted by 71.95% in 2023.
  • Cullinan Therapeutics' Other financing activities (Quarterly) stood at $13.7 million in 2020, then spiked by 58.25% to $21.7 million in 2021, then rose by 23.59% to $26.8 million in 2022, then tumbled by 71.95% to $7.5 million in 2023.
  • Its last three reported values are $7.5 million in Q4 2023, $7.7 million for Q3 2023, and $7.9 million during Q2 2023.